prof. dr. R.E.G. Schutgens

Full Professor
prof. dr. R.E.G. Schutgens
  • Hematology/Van Creveldclinic



Roger Schutgens is a Consultant Haematologist at the University Medical Centre Utrecht. His main responsibilities include care, research and education in the area of benign hematology and clotting diseases. Prof. Schutgens is the Head of at the Van Creveldkliniek, a national expertise center for rare and/or inherited benign hematologic disorders, thrombosis and haemostasis. He completed his medical degree from Catholic University Leuven, Leuven, Belgium and he completed his PhD from Utrecht University, Utrecht, The Netherlands. Prof. Schutgens areas of focus include patients predisposed to bleeding, congenital abnormalities of platelets and hypercoagulable conditions.

Side Activities

  • Advisory Board Member Horizonscan geneesmiddelen ZonMW since 1-10-2018

Research Output (199)

Oxygen gradient ektacytometry-derived biomarkers are associated with vaso-occlusive crises and correlate with treatment response in sickle cell disease

Rab Minke A E, Kanne Celeste K, Bos Jennifer, van Oirschot Brigitte A, Boisson Camille, Houwing Maite E, Gerritsma Jorn, Teske Erik, Renoux Celine, Riedl Jurgen, Schutgens Roger E G, Bartels Marije, Nur Erfan, Joly Philippe, Fort Romain, Cnossen Marjon H, van Wijk Richard, Connes Philippe, van Beers Eduard J, Sheehan Vivien A jan 2021, In: American Journal of Hematology. 96 , p. E29-E32 4 p.

DOAC in COVID-19:Yes or No?

Schutgens Roger E jan 2021, In: HemaSphere. 5 , p. e526

A feasibility study on two tailored interventions to improve adherence in adults with haemophilia

Hoefnagels Anne, Fischer Kathelijn, Bos Ruud, Driessens Mariette H E, Meijer Stephan, Schutgens Roger E, Schrijvers Marlies 1 dec 2020, In: BMC Pilot and Feasibilty studies. 6

Bleeding severity in patients with rare bleeding disorders:real-life data from the RBiN study

Saes Joline L, Verhagen Marieke J A, Meijer Karina, Cnossen Marjon H, Schutgens Roger E G, Peters Marjolein, Nieuwenhuizen Laurens, van der Meer Felix J M, Kruis Ilmar C, van Heerde Waander L, Schols Saskia E M 16 okt 2020, In: Blood Advances. 4 , p. 5025-5034 10 p.

Treatment of acquired hemophilia A, a balancing act:results from a 27-year Dutch cohort study

Schep Sarah J, van Dijk Wobke E M, Beckers Erik A M, Meijer Karina, Coppens Michiel, Eikenboom Jeroen, Leebeek Frank W G, van Vulpen Lize F D, Fischer Kathelijn F, Schutgens Roger E G, 10 okt 2020, In: American Journal of Hematology. 96 , p. 51-59 9 p.

Bleeding phenotype and diagnostic characterization of patients with congenital platelet defects

Blaauwgeers Maaike W., Kruip Marieke J.H.A., Beckers Erik A.M., Coppens Michiel, Eikenboom Jeroen, van Galen Karin P.M., Tamminga Rienk Y.J., Urbanus Rolf T., Schutgens Roger E.G. 1 okt 2020, In: American Journal of Hematology. 95 , p. 1142-1147 6 p.

Real-Life Pharmacokinetics of rFVIII-Fc and rFIX-Fc

Traets Marissa J M, Fischer Kathelijn, Uitslager Nanda, van der Valk Paul R, Kremer Hovinga Idske C L, van Vulpen Lize F D, Schutgens Roger E G okt 2020, In: TH open : companion journal to thrombosis and haemostasis. 4 , p. e362-e364

Obstetrical bleeding in women with MYH9-related disease:A systematic review

Punt Marieke C., Ruigrok Nienke D., Bloemenkamp Kitty W.M., Schutgens Roger E.G., Kremer Hovinga Idske C.L., van Galen Karin P.M. 30 sep 2020, In: Haemophilia. 6 p.

D-dimer in COVID-19:A Guide With Pitfalls

Schutgens Roger E aug 2020, In: HemaSphere. 4

A Pathophysiological Perspective on the SARS-CoV-2 Coagulopathy

Kusadasi Nuray, Sikma Maaike, Huisman Albert, Westerink Jan, Maas Coen, Schutgens Roger aug 2020, In: HemaSphere. 4 6 p.

All research output